Title : ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib.

Pub. Date : 2019 Jul 20

PMID : 31330833






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib. Sorafenib angiopoietin 2 Homo sapiens
2 Our results suggest that ANGPT2rs55633437 and NOS3 rs2070744 polymorphisms could identify a subset of HCC patients more resistant to sorafenib. Sorafenib angiopoietin 2 Homo sapiens